Xtx Topco LTD Kodiak Sciences Inc. Transaction History

Xtx Topco LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$3.01 - $7.45 $43,350 - $107,294	14,402 New	14,402 $75,000
Q3 2023 Nov 13, 2023	BUY	$1.8 - $7.49 $62,235 - $258,966	34,575 Added 140.81%	59,129 $106,000
Q2 2023 Aug 14, 2023	BUY	$4.3 - $9.48 $9,283 - $20,467	2,159 Added 9.64%	24,554 $169,000
Q1 2023 May 12, 2023	BUY	$4.81 - $8.88 $107,719 - $198,867	22,395 New	22,395 $138,000
Q2 2021 Aug 12, 2021	SELL	$77.2 - $126.54 $151,234 - $247,891	-1,959 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$110.45 - $164.47 $216,371 - $322,196	1,959 New	1,959 $222,000

39M

6.5K

5.8K

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $455M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.